Frontlight ResearchEarly access
CompletedNo phase
Comparison of Clinical Outcomes in Ziemer Femtosecond Versus Conventional Phacoemulsification Surgery
Key facts
- Who runs it
- Singapore Eye Research Institute
- Where
- Singapore1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 13 people enrolled
- Started
- Aug 2015
- Ended
- 28 Feb 2024
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Femtosecond laser assisted cataract surgery
- Conventional phacoemulsification
- Record updated
- 29 May 2025
Who can take part
- Age
- 55 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 21 criteriaShow less
Who can take part
- A cataract will be defined as clouding of the lens that interferes with normal vision
- Not relevant, as study not on cancer patients
- Only patients older than 50 years will be included, as cataracts develops with increasing age. No gender criteria are applied
- Only individuals with the mental capacity to provide informed consent with be included; More specifically, all the following inclusion criteria must be met:
- Patients have medically dilated pupil size of at least 4.0mm
- Patients are willing and able to sign a written Informed Consent Form prior to any study-specific procedures
- Patients are willing and able to return for scheduled follow-up examinations for 12 months after the cataract surgery
Who cannot take part
- Patients with prior history of pseudoexfoliation syndrome
- Patients with a prior history of glaucoma filtration surgery
- Patients with a prior history of vitrectomy
- Patients with a prior history of cataract or refractive lens surgery
- Patients with ocular pathology or disease (including pupil pathology such as fixated pupils) that might confound the outcome or increase the risk of adverse event
- Patients with residual, recurrent, active or uncontrolled eyelid disease
- Patients with any progressive retinal disease or subjects with a history or evidence of retinal vascular occlusion and/or hypercoagulability, because of the risks associated with high pressures during suction application
- Patients who are pregnant, lactating, of child-bearing potential and not practising a medically approved method of birth control, or planning to become pregnant during the course of the trial, and patients with other conditions associated with fluctuation of hormones that could lead to refractive changes
- Patients with optic atrophy
- Patients with central corneal scarring
- Patients with significant corneal asymmetry or irregular topography
- Patients with anterior segment pathology
- Patients with any corneal abnormality
- Patients with amblyopia or strabismus or those who are at risk for developing strabismus postoperatively as determined by corneal light reflex and cover-uncover testing
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study is aimed to compare the clinical outcomes in Ziemer LDV Z8 femtosecond laser-assisted cataract surgery versus conventional phacoemulsification cataract surgery
The 2 groups in the trial
- ConventionalPlacebo, for comparison
Conventional phacoemulsification surgery
Treatment: Conventional phacoemulsification
- Femtosecond laserExisting treatment, for comparison
Ziemer femtosecond laser assisted cataract surgery Intervention: Ziemer femtosecond laser assisted cataract surgery
Treatment: Femtosecond laser assisted cataract surgery
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Comparison of Clinical Outcomes in Ziemer LDV Z8 Femtosecond Laser-assisted Cataract Surgery
- Record updated
- 29 May 2025